Abcellera Biologics Inc. · NASDAQ:ABCL
Booth Andrew bought 37,200 Abcellera Biologics Inc. shares (Form 4)
Traded Aug 14, 2026 · Filed Aug 14, 2026
On Aug 14, 2026, Booth Andrew (Chief Financial Officer) bought 37,200 Abcellera Biologics Inc. shares at US$10.32 for US$384K, leaving 482,800 shares. Filed Aug 14, 2026 (Form 4).
- Bought
- 37,200 shares
- Price
- US$10.32
- Value
- US$384K
- Holding after
- 482,800 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 14, 2026 | Common Shares | Buy | 37,200 | US$10.32 | 482,800 | Direct |
Source
Related
- Abcellera Biologics Inc.
- Booth Andrew
- Abcellera Biologics Inc. shareholders
- Form 4 · Booth Andrew · Jun 3, 2026
- Form 4 · Hayden Michael R · Aug 24, 2026
- Form 4 · Montalbano John S. · Aug 18, 2026
- Form 4 · Hayden Michael R · Aug 14, 2026
- Form 4 · Hayden Michael R · Aug 13, 2026
- Form 4 · Montalbano John S. · May 18, 2026